Centene stock delivers 12.35% annual return over 20 years
Centene has delivered an average annual return of 12.35% over the last 20 years, outperforming the market by 2.95% annually. With a current market capitalization of $30.13 billion, a $100 investment made two decades ago would have grown to $992.20.

*this image is generated using AI for illustrative purposes only.
Centene has outperformed the market over the past 20 years by 2.95% on an annualized basis, generating an average annual return of 12.35%. The company currently holds a market capitalization of $30.13 billion. This performance highlights the impact of compounded returns on long-term investment growth.
Investment Growth Analysis
If an investor had purchased $100 of Centene stock 20 years ago, that investment would be worth $992.20 today. This calculation is based on a current price of $61.02 for Centene shares.
Key Financial Metrics
| Metric | Value |
|---|---|
| Average annual return | 12.35% |
| Market outperformance | 2.95% |
| Current market cap | $30.13 billion |
| Current share price | $61.02 |
The primary insight from this data is the significant effect compounded returns have on increasing the value of cash holdings over extended periods.
What factors could drive Centene's ability to sustain its historical outperformance in the next decade?
How might changes in healthcare policy impact Centene's future growth trajectory?
What are the risks to Centene's compounded returns given its current market valuation?
























